Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Zara A. Ioannides"'
Autor:
Zara A. Ioannides, Peter A. Csurhes, Nanette L. Douglas, Gem Mackenroth, Andrew Swayne, Kate M. Thompson, Tracey J. Hopkins, Kerryn A. Green, Stefan Blum, Kaye D. Hooper, Kerstin H. Wyssusek, Alan Coulthard, Michael P. Pender
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Background: Increasing evidence indicates a role for Epstein–Barr virus (EBV) in the pathogenesis of multiple sclerosis (MS). EBV-infected autoreactive B cells might accumulate in the central nervous system because of defective cytotoxic CD8+ T cel
Externí odkaz:
https://doaj.org/article/2a3646e3e6f84152b534845f60d8eb64
Autor:
Michael P. Pender, Peter A. Csurhes, Corey Smith, Nanette L. Douglas, Michelle A. Neller, Katherine K. Matthews, Leone Beagley, Sweera Rehan, Pauline Crooks, Tracey J. Hopkins, Stefan Blum, Kerryn A. Green, Zara A. Ioannides, Andrew Swayne, Blake T. Aftab, Kaye D. Hooper, Scott R. Burrows, Kate M. Thompson, Alan Coulthard, Rajiv Khanna
Publikováno v:
JCI Insight, Vol 5, Iss 20 (2020)
Externí odkaz:
https://doaj.org/article/5220d02d3d4a4acaa623d7dda4d52f6c
Autor:
P. Foubert, J. Lindsey, Simon Broadley, D. Munson, K. Rasor, F. Forozan, Michael P. Pender, Blake T. Aftab, Zara A. Ioannides, J. Willmer, Suzanne Hodgkinson, L. Gamelin, W. Ye
Publikováno v:
Multiple Sclerosis Journal. 25:890-938
Introduction: Evidence suggests Epstein-Barr virus (EBV) infection is associated with multiple sclerosis pathogenesis. In patients (pt) with progressive forms of MS (pMS), autologous EBV-specific T cells may prevent progression and improve symptoms (
Publikováno v:
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 18:486-491
Background: Anthropometric measurements including body mass index (BMI) and body adiposity index (BAI) are widely employed as indicators of fat mass (FM). Metabolic abnormalities in amyotrophic lateral sclerosis (ALS) impact disease progression, ther
Publikováno v:
Internal Medicine Journal. 47:1460-1462
Autor:
Michael P. Pender, P. Foubert, Peter A. Csurhes, Andrew Swayne, Zara A. Ioannides, Blake T. Aftab
Publikováno v:
Multiple Sclerosis Journal-Experimental, Translational and Clinical
Background Soluble triggering receptor expressed on myeloid cells-2 (sTREM-2) is a marker of macrophage and microglial activation and is increased in the cerebrospinal fluid (CSF) in multiple sclerosis (MS). Objective To determine the relationships a
Autor:
Nanette L. Douglas, Rajiv Khanna, Leone Beagley, Pauline Crooks, Zara A. Ioannides, Corey Smith, Michelle A Neller, Kate Thompson, Stefan Blum, Blake T. Aftab, Andrew Swayne, Alan Coulthard, Michael P. Pender, Sweera Rehan, Scott R. Burrows, Kaye D. Hooper, Kerryn A. Green, Tracey Hopkins, Katherine K. Matthews, Peter A. Csurhes
Publikováno v:
JCI Insight, Vol 5, Iss 20 (2020)
JCI Insight
JCI Insight
BACKGROUND. Increasing evidence indicates a role for EBV in the pathogenesis of multiple sclerosis (MS). EBV-infected autoreactive B cells might accumulate in the CNS because of defective cytotoxic CD8+ T cell immunity. We sought to determine the fea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fc611c8ac688e08c63e0506651eefeb
https://europepmc.org/articles/PMC6302936/
https://europepmc.org/articles/PMC6302936/
Autor:
Zara A. Ioannides, Susan Heggie, Naomi R. Wray, Kathryn A Thorpe, Frederik J. Steyn, Saman Heshmat, Leonard H. van den Berg, Pamela A. McCombe, Amelia Ceslis, Ruben P A van Eijk, Robert D. Henderson, Shyuan T. Ngo, Anjali K. Henders
Publikováno v:
Journal of Neurology, Neurosurgery, and Psychiatry
ObjectiveTo determine the prevalence of hypermetabolism, relative to body composition, in amyotrophic lateral sclerosis (ALS) and its relationship with clinical features of disease and survival.MethodsFifty-eight patients with clinically definite or
Autor:
Zara A. Ioannides
Background and objectives: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the relentless loss of upper motor neurones (UMN) and lower motor neurones (LMN), leading to progressive weakness. The cause of ALS i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad0f9e84713aeb1c65fe14efe16ca04b
https://doi.org/10.14264/uql.2017.829
https://doi.org/10.14264/uql.2017.829
Autor:
Pamela A. McCombe, Frederik J. Steyn, Zara A. Ioannides, Robert D. Henderson, Shyuan T. Ngo, J.D. Mi
Publikováno v:
Cogent Medicine, Vol 4, Iss 1 (2017)
Background: Hypermetabolism, defined as an increase in measured resting energy expenditure (mREE) relative to predicted REE (pREE), is recognised as an important feature of amyotrophic lateral sclerosis (ALS). Previous predictions of REE in ALS have